HomeDR6 • FRA
add
ACADIA Pharmaceuticals Inc
Previous close
€15.80
Day range
€15.57 - €15.57
Year range
€13.06 - €19.42
Market cap
2.85B USD
Avg Volume
29.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 259.60M | 12.36% |
Operating expense | 130.08M | 16.70% |
Net income | 143.74M | 213.87% |
Net profit margin | 55.37 | 179.36% |
Earnings per share | 0.86 | 207.14% |
EBITDA | 12.20M | -66.64% |
Effective tax rate | 10.77% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 755.99M | 72.26% |
Total assets | 1.19B | 58.59% |
Total liabilities | 454.96M | 43.43% |
Total equity | 732.79M | — |
Shares outstanding | 166.79M | — |
Price to book | 3.59 | — |
Return on assets | 1.61% | — |
Return on capital | 2.48% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 143.74M | 213.87% |
Cash from operations | 40.38M | -52.71% |
Cash from investing | 122.15M | 35,301.73% |
Cash from financing | 1.97M | -63.77% |
Net change in cash | 164.44M | 81.77% |
Free cash flow | 110.12M | 78.29% |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
654